Bedell Frazier Investment Counselling’s DexCom DXCM Stock Holding History

Bedell Frazier Investment Counselling’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-2,000	Closed	-$226K	–	92
2022 Q4	$226K	Buy	+2,000	New	+$220K	0.06%	98
2022 Q2	–	Sell	-2,000	Closed	-$256K	–	86
2022 Q1	$256K	Hold	2,000	–	–	0.06%	82
2021 Q4	$268K	Hold	2,000	–	–	0.07%	91
2021 Q3	$273K	Hold	2,000	–	–	0.08%	84
2021 Q2	$214K	Buy	+2,000	New	+$192K	0.05%	93
2020 Q4	–	Sell	-2,000	Closed	-$206K	–	80
2020 Q3	$206K	Hold	2,000	–	–	0.07%	72
2020 Q2	$203K	Buy	+2,000	New	+$179K	0.08%	63

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Bedell Frazier Investment Counselling's DXCM Position: Q1 2023 in Review

Bedell Frazier Investment Counselling sold out of DexCom (DXCM) in Q1 2023, closing a stake of 2,000 shares — an estimated $226K sold.

Bedell Frazier Investment Counselling first reported a position in DXCM in Q2 2020 and held it in 7 quarters. The position peaked at $273K in Q3 2021. 905 funds tracked by Wall St. Rank hold DXCM as of Q1 2023.

Bedell Frazier Investment Counselling reported no remaining DexCom position as of Q1 2023 after selling out during the quarter.
Bedell Frazier Investment Counselling sold 2,000 DexCom shares in Q1 2023, an estimated $226K.
Bedell Frazier Investment Counselling first reported a position in DexCom in Q2 2020 and held it in 7 quarters.
Bedell Frazier Investment Counselling's DexCom position peaked at $273K in Q3 2021.
905 funds tracked by Wall St. Rank held DexCom as of Q1 2023.

Based on Bedell Frazier Investment Counselling's 13F filing for Q1 2023, filed 9 May 2023.